Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CareDx

Explore full profile

Innovative noninvasive testing solutions enhancing transplant patient outcomes throughout their journey

Brisbane, United StatesFounded 2000Biotech & Life Sciences
Valuation $1.91B Market cap · Aug/2026
Revenue $462M Latest reported FY
EBITDA $52M Latest reported FY

At a glance

Founded
2000
Headquarters
Brisbane, United States
Listing
IPO 2014
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later4 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 57 incl. 12 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States50%
🇵🇪 Peru12.5%
🇬🇧 United Kingdom12.5%
🇲🇽 Mexico12.5%
🇨🇴 Colombia12.5%
5 countries shown
Web traffic by country
18K monthly visits
across markets
🇺🇸 United States72.2%
🇨🇦 Canada11.1%
🇮🇳 India6.1%
🇸🇪 Sweden5%
🇵🇭 Philippines2.8%
Top 5 markets shown

Patents

Estimated portfolio value
$2M

4 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where CareDx was the backer or acquirer, 2015–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across CareDx's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where CareDx deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        CareDx's portfolio, mapped.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about CareDx on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See CareDx on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles